In line with U.S. orthopedic trends spotted across the market, Stryker (Kalamazoo, Mich.) has delivered a minimum of 5 percent organic sales growth for the tenth consecutive quarter, although weak international sales did drag growth to 5.3 percent compared to the 6.9 percent growth Stryker reported in the second quarter. Kevin Lobo, Stryker's chairman/CEO, said all three business segments delivered year-over-year sales growth during the third quarter, driven by strong U.S. momentum and the company's diversified model.